X

Vous n'êtes pas connecté

Articles similaires

Sorry! Image not available at this time

Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis

mangaloremirror.com - 02/Jul 12:37

– Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 – – EU...

Sorry! Image not available at this time

Epkinly (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

drugs.com - 27/Jun 04:06

COPENHAGEN, Denmark; June 27, 2024 – Genmab A/S (Nasdaq: GMAB) today announced that the U.S. Food and Drug Administration (FDA) has approved...

Sorry! Image not available at this time

Truist (TFC) Declares SCB, Rewards Shareholders With Buyback Plan

zacks.com - 02/Jul 12:02

Truist's (TFC) board of directors has approved a share repurchase authorization worth $5 billion through 2026, following the clearance of the 2024...

Sorry! Image not available at this time

Truist (TFC) Declares SCB, Rewards Shareholders With Buyback Plan

zacks.com - 02/Jul 12:02

Truist's (TFC) board of directors has approved a share repurchase authorization worth $5 billion through 2026, following the clearance of the 2024...

Sorry! Image not available at this time

SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

drugs.com - 01/Jul 06:07

STAMFORD, Conn., July 01, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused...

Sorry! Image not available at this time

EG 427 receives US FDA clearance to initiate phase 1b/2a study of gene therapy, EG110A to treat NDO in spinal cord injury patients

pharmabiz.com - 26/Jun 00:00

EG 427, a biotechnology company leading the development of pinpoint DNA medicines for prevalent diseases in neurology based on its unique...

Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization

news.medical.net - 22/Jun 06:24

Sobi® today announced the European Commission has granted Marketing Authorization for ALTUVOCT™ (efanesoctocog alfa), for the treatment and...

Four Ways AI Helps Emerging E-Commerce Platforms Compete with Major Game Distributors

unite.ai - 01/Jul 16:04

Over the past 12 years, computer and video game distribution strategies have undergone a seismic shift. Sales of digital games exceeded those of...